Azacitidine for the treatment of lower r
β
Pellegrino Musto; Luca Maurillo; Alessandra Spagnoli; Antonella Gozzini; Flavia
π
Article
π
2010
π
John Wiley and Sons
π
English
β 203 KB
π 2 views
## Abstract ## BACKGROUND: Azacitidine induces responses and prolongs overall survival compared with conventional care regimens in patients who have highβrisk myelodysplastic syndromes (MDS). However, limited data are available concerning the efficacy and safety of azacitidine in patients who have